PURPOSE: In this study, we wished to compare statistically the novel SORG algorithm in predicting survival in spine metastatic disease versus currently used methods. METHODS: We recruited 40 patients with spinal metastatic disease who were operated at Geneva University Hospitals by the Neurosurgery or Orthopedic teams between the years of 2015 and 2020. We did an ROC analysis in order to determine the accuracy of the SORG ML algorithm and nomogram versus the Tokuhashi original and revised scores. RESULTS: The analysis of data of our independent cohort shows a clear advantage in terms of predictive ability of the SORG ML algorithm and nomogram in comparison with the Tokuhashi scores. The SORG ML had an AUC of 0.87 for 90 days and 0.85 for 1 year. The SORG nomogram showed a predictive ability at 90 days and 1 year with AUCs of 0.87 and 0.76 respectively. These results showed excellent discriminative ability as compared with the Tokuhashi original score which achieved AUCs of 0.70 and 0.69 and the Tokuhashi revised score which had AUCs of 0.65 and 0.71 for 3 months and 1 year respectively. CONCLUSION: The predictive ability of the SORG ML algorithm and nomogram was superior to currently used preoperative survival estimation scores for spinal metastatic disease.
PURPOSE: In this study, we wished to compare statistically the novel SORG algorithm in predicting survival in spine metastatic disease versus currently used methods. METHODS: We recruited 40 patients with spinal metastatic disease who were operated at Geneva University Hospitals by the Neurosurgery or Orthopedic teams between the years of 2015 and 2020. We did an ROC analysis in order to determine the accuracy of the SORG ML algorithm and nomogram versus the Tokuhashi original and revised scores. RESULTS: The analysis of data of our independent cohort shows a clear advantage in terms of predictive ability of the SORG ML algorithm and nomogram in comparison with the Tokuhashi scores. The SORG ML had an AUC of 0.87 for 90 days and 0.85 for 1 year. The SORG nomogram showed a predictive ability at 90 days and 1 year with AUCs of 0.87 and 0.76 respectively. These results showed excellent discriminative ability as compared with the Tokuhashi original score which achieved AUCs of 0.70 and 0.69 and the Tokuhashi revised score which had AUCs of 0.65 and 0.71 for 3 months and 1 year respectively. CONCLUSION: The predictive ability of the SORG ML algorithm and nomogram was superior to currently used preoperative survival estimation scores for spinal metastatic disease.
Authors: C Bouthors; S Prost; C Court; B Blondel; Y P Charles; S Fuentes; H P Mousselard; C Mazel; C H Flouzat-Lachaniette; P Bonnevialle; F Saihlan Journal: Support Care Cancer Date: 2019-08-09 Impact factor: 3.603
Authors: A Karim Ahmed; C Rory Goodwin; Amir Heravi; Rachel Kim; Nancy Abu-Bonsrah; Eric Sankey; Daniel Kerekes; Rafael De la Garza Ramos; Joseph Schwab; Daniel M Sciubba Journal: Spine J Date: 2018-03-19 Impact factor: 4.166
Authors: Aditya V Karhade; Quirina C B S Thio; Paul T Ogink; Christopher M Bono; Marco L Ferrone; Kevin S Oh; Philip J Saylor; Andrew J Schoenfeld; John H Shin; Mitchel B Harris; Joseph H Schwab Journal: Neurosurgery Date: 2019-10-01 Impact factor: 4.654
Authors: Olivier Q Groot; Dennis Hundersmarck; Amanda Lans; Michiel E R Bongers; Aditya V Karhade; Yue Zhang; Floris R van Tol; Jorrit-Jan Verlaan; Jahan Mohebali; Joseph H Schwab Journal: Spine J Date: 2020-11-03 Impact factor: 4.166
Authors: Laurens Bollen; Yvette M van der Linden; Willem Pondaag; Marta Fiocco; Bas P M Pattynama; Corrie A M Marijnen; Rob G H H Nelissen; Wilco C Peul; P D Sander Dijkstra Journal: Neuro Oncol Date: 2014-07 Impact factor: 12.300
Authors: Aditya V Karhade; Ali K Ahmed; Zach Pennington; Alejandro Chara; Andrew Schilling; Quirina C B S Thio; Paul T Ogink; Daniel M Sciubba; Joseph H Schwab Journal: Spine J Date: 2019-09-07 Impact factor: 4.166
Authors: Jonathan Agner Forsberg; Rikard Wedin; Henrik C F Bauer; Bjarne H Hansen; Minna Laitinen; Clement S Trovik; Johnny Ø Keller; Patrick J Boland; John H Healey Journal: BMC Cancer Date: 2012-10-25 Impact factor: 4.430